Venetoclax and Bortezomib in Relapsed/Refractory Early T-Cell Precursor Acute Lymphoblastic Leukemia

JCO Precis Oncol. 2019 Sep 20:3:PO.19.00172. doi: 10.1200/PO.19.00172. eCollection 2019.
No abstract available